Development of Graves' disease in a patient under immunosuppressive therapy after liver transplantation

Journal of Endocrinological Investigation

Volumn 26, Issue 3, 2003, Pages 257-260

  Bednarczuk, T ^a,b   Makowska, U ^a,b   Nauman, Janusz ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

CTLA 4; Cyclosporin A; Graves' disease; HLA DR; Prednisone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBODY; ANTITHYROID AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CALCIUM; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN; IODINE 123; LEVOTHYROXINE; LIOTHYRONINE; PREDNISONE; RADIOACTIVE IODINE; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN BINDING INHIBITOR; THYROXINE; UNCLASSIFIED DRUG; VITAMIN D;

ADOLESCENT; ALLELE; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DELTA AGENT HEPATITIS; DIARRHEA; DNA POLYMORPHISM; DRUG BLOOD LEVEL; EXON; FATIGUE; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GRAFT REJECTION; GRAVES DISEASE; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IODINE 131 UPTAKE TEST; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TOXICITY; LIVER TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; POSITRON; WEIGHT REDUCTION;

EID: 0038204206     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345166     Document Type: Article

References (16)

1. Krassas G.E, Heufelder A.E. Immunosuppresive therapy in patients with thyroid eye disease: An overview of current concepts. Eur. J. Endocrinol. 2001, 144: 311-318.
2. Weetman A.P., McGregory A.M., Ludgate M. Cyclosporin improves Graves' ophthalmopathy. Lancet 1983, 2: 486-489.
3. Prummel M.F., Mourits M.P., Berghout A. et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N. Engl. J. Med. 1989, 321: 1353-1359.
4. Balazs C., Kiss E., Farid N.R. Time-dependent effect of cyclosporin-A on the TSH receptor antibody synthesis in patients with Graves' disease. Acta Med. Hung. 1988, 45: 43-52.
5. Hofle G., Moncayo R, Baldiserra I, Pfister R, Finkenstedt G. Endocrine ophthalmopathy in a patient under continous immunosuppressive therapy after cardiac transplantation. Thyroid 1996, 6: 253.
6. Wortsman J., McConnachie P., Tahara K, Kohn L.D. Thytropin receptor epitopes recognized by Graves' autoantibodies developing under immunosuppressive therapy. J. Clin. Endocrinol. Metab. 1998, 83: 2302-2308.
7. Khovidhunkit W., Greenspan F.S., Jauma J.C. Development of overt autoimmune hyperthyroidism in a patient therapeutically immunosuppressed after liver transplantation. Thyroid 2000, 10: 829-832.
8. Thomson J.A., Wilson R., Walker I.D. The development of thyrotoxicosis (Graves' disease) during immunosuppression for autoimmune haemolytic anaemia. Acta Endocrinol. 1986, 112: 531-535.
9. Todd A., Todd J. Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin. Lab. Haematol. 1999, 21: 69-70.
10. Vaidya B, Imrie H, Perros P. et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated ophthalmopathy. Lancet 1999, 354: 743-744.
11. Weetman A.P. Graves' disease. N. Engl. J. Med. 2000, 343: 1236-1248.
12. Gough S.C. The genetics of Graves' disease. Endocrinol. Metab. Clin. North. Am. 2000, 29: 255-266.
13. Lohman T., List C., Lamesch P. et al. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunosuppressive therapy by FK506/tacrolimus. Exp. Clin. Endocrinol. Diab. 2000, 108: 347-52.
14. Donner H., Rau H., Walfish P.G. et al. CTLA-4 Alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 1997, 82: 143-146.
15. Klein J., Sato A. The HLA system. N. Engl. J. Med. 2000, 343: 782-786.
16. Tomer Y., Greenberg D.A., Concepcion E., Ban Y., Davies T.F. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 2002, 87: 407-407.